DEDTP Exposure: Ethyl-Type Organophosphate Sources and What It May Signal

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

This test measures DEDTP, a urinary biomarker of exposure to diethyl organophosphate pesticides, helping you identify and reduce harmful pesticide exposure. By addressing elevated levels, you may lower the risk of pesticide-related nervous system effects such as headaches, dizziness, cognitive issues, and potential developmental harms.

Read more →

Understand what your environmental toxins results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

DEDTP: A urinary footprint of ethyl-type organophosphates

Diethyldithiophosphate (DEDTP) is a dialkyl phosphate metabolite formed when the body breaks down certain ethyl-based organophosphate (OP) insecticides. You won’t find DEDTP on a product label; it’s a downstream marker your body produces after contact with multiple OPs used in agriculture and some pest-control settings. Most people encounter OP residues through food, dust, or air near treated areas, with smaller contributions from skin contact. Laboratories typically measure DEDTP in urine using mass spectrometry. Because OPs clear relatively quickly, a urine DEDTP result reflects recent exposure, often within the past 24–72 hours, rather than a long-term body burden.

Why DEDTP is worth measuring

Why it matters is about biology and timing. OP insecticides work by inhibiting acetylcholinesterase in insects; at high doses in humans, that same pathway can cause cholinergic symptoms. At everyday environmental levels, the concerns shift toward potential nervous system effects, oxidative stress, and the workload placed on liver and kidney pathways that process and excrete these compounds. DEDTP itself is a biomarker, not a toxin causing symptoms, but it signals that your body recently encountered OPs that produce diethyl-type metabolites. It does not pinpoint a specific pesticide and it can be influenced by “preformed” breakdown products already present on foods, which is why context and trends are key.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Who tends to find DEDTP testing most useful

Testing provides a reality check on exposure you cannot see or taste. If your result is detectable, it indicates recent contact with ethyl-type OP insecticides common in agricultural settings. That can help distinguish a one-off dietary spike from a pattern that aligns with your routine, home environment, or work. People who live with or near agricultural activity, handle produce frequently, or work in pest management may find this distinction especially useful. In clinical research, higher prenatal OP exposure has been associated with neurodevelopmental differences in children, though results vary by study and exposure level. For anyone planning pregnancy or navigating early childhood environments, understanding whether exposures are elevated during these sensitive windows can be reassuring or a prompt to investigate sources further.

Reading a DEDTP result

Labs usually report urinary DEDTP relative to population-based reference data, sometimes with creatinine correction to account for hydration. Because OPs are non-persistent, lower values generally suggest minimal recent contact, while higher values suggest a recent or ongoing source. Timing matters: results can move day to day with meals, workplace tasks, or home activities. That’s why repeat measurements and noting recent exposures make interpretation stronger.

Relatively low values typically indicate limited recent exposure and a lower likelihood of short-term system stress from OPs that metabolize to DEDTP. In population surveys, DEDTP is often detected less frequently than some related metabolites, so a non-detect is common and usually consistent with low exposure. For pregnancy and early childhood, lower urinary OP metabolites are generally preferred given developing nervous systems, although individual results still need context from overall patterns and clinical history.

Relatively higher values can reflect recent dietary intake of treated produce, contact with spray residues, or work in or around treated fields. They don’t diagnose toxicity, but they can imply more biochemical processing through hepatic and renal pathways, and, depending on total OP exposure, potential stress on cholinergic signaling. If elevated values cluster with headaches, dizziness, or unusual fatigue after specific tasks, that pattern may merit a closer look, especially for those in agriculture or pest control. Still, urinary DEDTP does not identify the specific pesticide or quantify enzyme inhibition; it’s a flag to consider timing, co-exposures, other OP metabolites, and, when relevant, cholinesterase measurements.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

What to interpret DEDTP alongside

Big-picture, a DEDTP result is most informative alongside other data. Patterns across the six common dialkyl phosphate metabolites (the broader OP family), general health markers, and symptoms create a fuller picture than any single number. For occupational questions, blood cholinesterase testing can complement urinary OP metabolites because it tracks the biological effect of certain OPs rather than just exposure. Over time, repeating DEDTP within the same lab method can show whether an initial result was a blip or part of a sustained pattern. The goal is not to chase a perfect zero, but to understand your baseline and what meaningfully shifts it.

What a DEDTP test can and can't tell you

The most useful takeaways emerge when you connect DEDTP with related biomarkers, general health indicators, and lived context. Creatinine-corrected results compared over time help separate a transient spike from a sustained exposure pattern. Observing how values move alongside changes in environment, season, or job duties can clarify which factors matter for you. That’s the pragmatic value of this test: turning invisible exposures into understandable signals you can discuss with your clinician, using evidence and trends rather than assumptions.

Frequently Asked Questions

References

  1. Costa LG (2006). Current issues in organophosphate toxicology. *Clinica Chimica Acta*, *366*(1-2), 1-13. https://doi.org/10.1016/j.cca.2005.10.008
  2. Barr DB, Wong LY, Bravo R, Weerasekera G, Odetokun M, Restrepo P, Kim DG, Fernandez C, Whitehead RD, Perez J, Gallegos M, Williams BL, Needham LL (2011). Urinary concentrations of dialkylphosphate metabolites of organophosphorus pesticides: National Health and Nutrition Examination Survey 1999-2004. *International Journal of Environmental Research and Public Health*, *8*(8), 3063-3098. https://doi.org/10.3390/ijerph8083063
  3. Chen L, Zhao T, Pan C, Ross JH, Krieger RI (2012). Preformed biomarkers including dialkylphosphates (DAPs) in produce may confound biomonitoring in pesticide exposure and risk assessment. *Journal of Agricultural and Food Chemistry*, *60*(36), 9342-9351. https://doi.org/10.1021/jf303116p
  4. Bouchard MF, Chevrier J, Harley KG, Kogut K, Vedar M, Calderon N, Trujillo C, Johnson C, Bradman A, Barr DB, Eskenazi B (2011). Prenatal exposure to organophosphate pesticides and IQ in 7-year-old children. *Environmental Health Perspectives*, *119*(8), 1189-1195. https://doi.org/10.1289/ehp.1003185
  5. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL (2005). Urinary creatinine concentrations in the U.S. population: Implications for urinary biologic monitoring measurements. *Environmental Health Perspectives*, *113*(2), 192-200. https://doi.org/10.1289/ehp.7337

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey